Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B. (Q47589759)
Jump to navigation
Jump to search
scientific article published on 2 November 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B. |
scientific article published on 2 November 2017 |
Statements
1 reference
Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B. (English)
1 reference
Harry L A Janssen
Benedetta Massetto
Anh-Hoa Nguyen
Adarsh Joshi
Jacky Woo
Audrey H Lau
Anuj Gaggar
G Mani Subramanian
Eric M Yoshida
Naoky C S Tsai
Scott Fung
2 November 2017
1 reference